Pilot Study of Hyperfractionated Dosing of Lutetium‐177–Labeled Antiprostate‐Specific Membrane Antigen Monoclonal Antibody J591 ( 177 Lu‐J591) for Metastatic Castration‐Resistant Prostate Cancer

Oncologist - United States
doi 10.1634/theoncologist.2020-0028
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

[ 177 Lu]-Psma-617 Radionuclide Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer – Author's Reply

The Lancet Oncology
Oncology
2018English

Prostate-Specific Membrane Antigen–Directed Therapy for Metastatic Castration-Resistant Prostate Cancer

Cancer Journal
Cancer ResearchOncology
2016English

Prostate-Specific Membrane Antigen Based Antibody-Drug Conjugates for Metastatic Castration-Resistance Prostate Cancer

Cureus
2020English

A Prospective Pilot Study of 89Zr-J591/Prostate Specific Membrane Antigen Positron Emission Tomography in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy

Journal of Urology
Urology
2014English

Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer With 177 Lu-Psma-617

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

A Phase II Trial of Prostate-Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC) in Taxane-Refractory Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Dosimetry of Lu-177 PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pre-Therapeutic Imaging and “Whole Body” Tumor Dosimetry With Treatment Outcomes

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Radioimmunotherapy of Prostate Cancer Using 90y- And 177Lu-Labeled J591 Monoclonal Antibodies: Effect of Multiple Treatments on Myelotoxicity

Clinical Cancer Research
Cancer ResearchOncology
2005English

Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy